Julien Van Damme (@vandamme_jvd) 's Twitter Profile
Julien Van Damme

@vandamme_jvd

ID: 857119723783426048

calendar_today26-04-2017 06:30:41

33 Tweet

66 Takipçi

128 Takip Edilen

Scientific Summits (@scisummits) 's Twitter Profile Photo

REMINDER! Important novelties in the field of urothelial, prostate and kidney cancer will be covered by national & international top experts in the field. @PSUrol Full program & registration: scientificsummits.eu/events/scienti… #urology #oncology #cancer #conference

REMINDER! Important novelties in the field of urothelial, prostate and kidney cancer will be covered by national & international top experts in the field. @PSUrol Full program & registration: scientificsummits.eu/events/scienti… #urology #oncology #cancer #conference
EORTC GUCG YI (@eortc_gucg_yeci) 's Twitter Profile Photo

Nice talk by Dr Masson-Lecomte on the importance of defining the response to NAT, as well as the importance of multimodal assessment. Question will be answered by the EORTC2418 - ‘STARBURST’ study !#EORTC #EMUC24 Yohann Loriot Vérane Achard Julien Van Damme Guillaume Grs tombal

Nice talk by Dr Masson-Lecomte on the importance of defining the response to NAT, as well as the importance of multimodal assessment.  Question will be answered by the EORTC2418 - ‘STARBURST’ study !#EORTC #EMUC24 <a href="/y_loriot/">Yohann Loriot</a> <a href="/Achard_Verane/">Vérane Achard</a> <a href="/vandamme_jvd/">Julien Van Damme</a> <a href="/GGrisay/">Guillaume Grs</a> <a href="/BertrandTOMBAL/">tombal</a>
Mirrors of Medicine (@mirrorsmed) 's Twitter Profile Photo

Check out our free 20-minute webinar with a multidisciplinary panel of experts discussing the most recent data from clinical trials, treatment (de)escalation, and the role of ultra-low PSA in #mHSPC Register for free at library.mirrorsmed.org/?utm_code=SoMe… Julien Van Damme OncoAlert #GU

Check out our free 20-minute webinar with a multidisciplinary panel of experts discussing the most recent data from clinical trials, treatment (de)escalation, and the role of ultra-low PSA in #mHSPC
Register for free at library.mirrorsmed.org/?utm_code=SoMe… 
<a href="/vandamme_jvd/">Julien Van Damme</a> <a href="/OncoAlert/">OncoAlert</a> #GU
Vérane Achard (@achard_verane) 's Twitter Profile Photo

Great to see #EORTC2418 - STARBURST1 being presented at #GU25! Validating a clinical multimodal signature of response to NAT in MIBC is a crucial step towards more personalized treatment strategies. Honored to be part of this important study alongside such a dedicated team!

EORTC (@eortc) 's Twitter Profile Photo

🚀Congratulations to Dr Guillaume Grs & Dr Julien Van Damme for presenting the groundbreaking EORTC-2418-GUCG STARBURST-1 study last week at #ASCOGU in San Francisco! This study aims to redefine treatment for muscle-invasive #BladderCancer. 👉urotoday.com/conference-hig… ASCO

tombal (@bertrandtombal) 's Twitter Profile Photo

Fast (< 30 min) “All-in-One” whole-body MRI for TNM staging in high-risk prostate cancer (PCa), clearly an alternative Cliniques universitaires Saint-Luc Irene -IX ejradiology.com/article/S0720-…

Guillaume Grs (@ggrisay) 's Twitter Profile Photo

🚨 Defining clinical response to neoadjuvant CT in bladder is crucial to offer bladder-sparing strategies in complete or near cplt responders ! EORTC Starbust-1 will launch soon Alex Masson-Lecomte EORTC Yohann Loriot tombal Vérane Achard Julien Van Damme sciencedirect.com/science/articl…

ANZUP (@anzuptrials) 's Twitter Profile Photo

Well done! The @ANZUPTrials #BCGMM trial has been presented @ASCO25 showing BCG plus mitomycin a safe & effective alternative to BCG alone & the added benefit of requiring 40% fewer BCG doses. Congrats to Prof Dickon Hayne & team Ian Davis NHMRC CTC @MSD_Aus #OmegaPharm

Well done! The @ANZUPTrials #BCGMM trial has been presented @ASCO25 showing BCG plus mitomycin a safe &amp; effective alternative to BCG alone &amp; the added benefit of requiring 40% fewer BCG doses. Congrats to Prof Dickon Hayne &amp; team <a href="/Prof_IanD/">Ian Davis</a> <a href="/TrialsCentre/">NHMRC CTC</a> @MSD_Aus #OmegaPharm
Mirrors of Medicine (@mirrorsmed) 's Twitter Profile Photo

How exciting to see all these new data at #ASCO25! 👀 Interested to hear how these data are translated to your clinical practice? 👂 At the Global Forum on GU Oncology, the impact of the latest findings on #RenalCancer, #BladderCancer and #ProstateCancer are discussed in a

How exciting to see all these new data at #ASCO25! 👀 Interested to hear how these data are translated to your clinical practice? 👂 
At the Global Forum on GU Oncology, the impact of the latest findings on #RenalCancer, #BladderCancer and #ProstateCancer are discussed in a